London man among thousands who've rolled up their sleeves to trial Lyme disease vaccine

The clinical trial for the potential vaccine, VLA15, began in August 2022. Stage 3 trials got underway in late 2023, involving more than 9,000 participants from areas of Canada, Europe, and the U.S. where the disease is endemic.

from CBC | Technology News https://ift.tt/wsX9PmG